Nephrology Dialysis Transplantation, Vol 12, Issue 3 443-448, Copyright © 1997 by Oxford University Press
C Caenazzo, S Garbisa, M Onisto, M Zampieri, B Baggio and G Gambaro
Mesangial cells are responsible for the synthesis of mesangial matrix as
well as its degradation, which is mediated by a number of proteolytic
activities, including metalloproteinases (MMPs). Imbalanced matrix protein
metabolism may be responsible for mesangial expansion and
glomerulosclerosis in diabetic nephropathy. Heparin prevents this
complication. In human and murine mesangial cell cultures, RT-PCR was able
to detect mRNA expression for a number of molecules involved in the
mesangial extracellular matrix turnover: type IV collagen [alpha
1(IV)COLL], MMP-1, MMP-2, MMP-3, MMP-9 and MMP-10, and the tissue
inhibitors TIMP-1 and TIMP-2. The expression of mRNA for alpha 1(IV)COLL
and MMP-2/TIMP-2 balance was studied in human cells in the presence of high
glucose and heparin. mRNAs for all the studied molecules were expressed at
different levels. Interestingly, a shift in the balance of alpha 1(IV)COLL,
MMP-2 and TIMP-2 was observed in high glucose, which was partially reversed
by heparin supplementation. The new equilibrium was mostly due to the
down-regulation of type IV collagen expression, rather than further
reduction of potential proteolysis. Our data, while extending the list of
potential mediators of mesangial matrix catabolism, highlight a molecular
mechanism by which the pathogenesis of diabetic nephropathy may be
sustained, and at the same time suggest that heparin may have the potential
to correct this abnormality.
ORIGINAL ARTICLES
Effect of glucose and heparin on mesangial alpha 1(IV)COLL and MMP- 2/TIMP-2 mRNA expression
Institute of Histology and Embriology, Medical School, Padova, Italy.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
O. LENZ, S. J. ELLIOT, and W. G. STETLER-STEVENSON Matrix Metalloproteinases in Renal Development and Disease J. Am. Soc. Nephrol., March 1, 2000; 11(3): 574 - 581. [Full Text] [PDF] |
||||
![]() |
G. GAMBARO and F. J. VAN DER WOUDE Glycosaminoglycans: Use in Treatment of DiabeticNephropathy J. Am. Soc. Nephrol., February 1, 2000; 11(2): 359 - 368. [Full Text] [PDF] |
||||
![]() |
S. J. ELLIOT, L. J. STRIKER, W. G. STETLER-STEVENSON, T. A. JACOT, and G. E. STRIKER Pentosan Polysulfate Decreases Proliferation and Net Extracellular Matrix Production in Mouse Mesangial Cells J. Am. Soc. Nephrol., January 1, 1999; 10(1): 62 - 68. [Abstract] [Full Text] |
||||
